Medpace Holdings Inc vs NetEase Inc — how do they compare? Medpace Holdings Inc trades at $530.22 (market cap $15.08B), while NetEase Inc trades at $134.95 (market cap $86.14B). The key difference: NetEase Inc is far larger — about 5.7× Medpace Holdings Inc's market cap, and NetEase Inc pays a 2.25% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | NTES | |
|---|---|---|
Market Cap | $15.08B | $86.14B |
Sector | Technology | Media |
52-Week High | $620.59 | $159.34 |
52-Week Low | $308.88 | $109.26 |
Enterprise Value | $14.55B | $62.61B |
Dividend Yield | — | 2.25% |
Trailing returns across standard periods
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →